NOX4 and cancer: For the abundant fibrous stroma observed in C4 subclass, anti-fibrosis drugs (like NOX4 inhibitor) suppressed the activation of cancer-associated fibroblasts and promoted the infiltration of CD8+ T cells, ultimately improving the efficacy of immunotherapy (42).